Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

Abstract

Background Despite treatment, there is often a higher incidence of cardiovascular complications in patients with hypertension than in normotensive individuals. Inadequate reduction of their blood pressure is a likely cause, but the optimum target blood pressure is not known. The impact of acetylsalicylic acid (aspirin) has never been investigated in patients with hypertension. We aimed to assess the optimum target diastolic blood pressure and the potential benefit of a low dose of acetylsalicylic acid in the treatment of hypertension. Methods 18790 patients, from 26 countries, aged 50-80 years (mean 61.5 years) with hypertension and diastolic blood pressure between 100 mm Hg and 115 mm Hg (mean 105 mm Hg) were randomly assigned a target diastolic blood pressure. 6264 patients were allocated to the target pressure Findings Diastolic blood pressure was reduced by 20.3 mm Hg, 22.3 mm Hg, and 24.3 mm Hg, in the Interpretation Intensive lowering of blood pressure in patients with hypertension was associated with a low rate of cardiovascular events. The HOT Study shows the benefits of lowering the diastolic blood pressure down to 82.6 mm Hg. Acetylsalicylic acid significantly reduced major cardiovascular events with the greatest benefit seen in all myocardial infarction. There was no effect on the incidence of stroke or fatal bleeds, but non-fatal major bleeds were twice as common.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(98)04311-6

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 36 references

Research works printed but not linked: 3

  1. Zanchetti, 1992, To what level should blood pressure be brought by antihypertensive treatment?, High Blood Press, 1, 197
  2. O'Brien, 1993, The British Hypertension Society protocol for the evaluation of blood pressure measuring devices, J Hypertens, 11, S43
  3. 1985, Cardiovascular risk and factors in a randomised trial of treatment based on the beta-blocker oxprenolol: The International Prospective Primary Prevention Study in Hypertensives (IPPPSH), J Hypertens, 36, 379

Cited by

See all 5,728

Metadata

Authors
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S.
Affiliations
  • Uppsala University (SE)
  • University of Milan (IT)
  • Western University (CA)
  • Sahlgrenska University Hospital (SE)
  • University of Michigan (US)
  • University of Münster (DE)
  • Nordic School of Public Health (SE)
Corresponding author
Hansson, Lennart
Venue
The Lancet
Publisher
Elsevier BV
Published
1998-06
Volume
351
Issue
9118
Pages
1755-1762
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2137408480
Cited by
5,728
References
36
Citations by year
2026: 17 · 2025: 40 · 2024: 51 · 2023: 74 · 2022: 86 · 2021: 78 · 2020: 80 · 2019: 105 · 2018: 142 · 2017: 131 · 2016: 156 · 2015: 127 · 2014: 169 · 2013: 190 · 2012: 219
FWCI
236.67
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
hypertension, intensive blood pressure lowering, low-dose aspirin, aspirin, blood pressure targets, diastolic blood pressure, cardiovascular events, cardiovascular mortality, myocardial infarction, diabetes mellitus, felodipine, antihypertensive therapy, older adults, stroke prevention, bleeding risk
MeSH terms
Aged, Aged, 80 and over, Anti-Inflammatory Agents, Non-Steroidal, Antihypertensive Agents, Aspirin, Blood Pressure, Cardiovascular Diseases, Drug Therapy, Combination, Electrocardiography, Female, Humans, Hypertension, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. https://app.cochat.ai/papers/10.1016/s0140-6736(98)04311-6
The paper
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998). Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. The Lancet. https://doi.org/10.1016/s0140-6736(98)04311-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.